MV140 mucosal bacterial vaccine improves uropathogenic E. coli clearance in an experimental model of urinary tract infection

MV140 is a mucosal vaccine of inactivated whole bacteria (E. coli, K. pneumoniae, E. faecalis, P. vulgaris) with clinical efficacy against recurrent urinary tract infections (UTIs). Here, MV140 was evaluated in a murine model of acute uropathogenic E. coli (UPEC)-induced UTI using the UTI89 strain....

Descripción completa

Detalles Bibliográficos
Autores principales: Saz-Leal, Paula, Ligon, Marianne M., Diez-Rivero, Carmen M., García-Ayuso, Diego, Mohanty, Soumitra, Conejero, Laura, Brauner, Annelie, Subiza, José L., Mysorekar, Indira U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275044/
https://www.ncbi.nlm.nih.gov/pubmed/37333312
http://dx.doi.org/10.21203/rs.3.rs-2992611/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275044/
https://www.ncbi.nlm.nih.gov/pubmed/37333312
http://dx.doi.org/10.21203/rs.3.rs-2992611/v1

Ejemplares similares